CAPRICOR THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Liabilities
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2019-03-29
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2017-12-31 was $276.26K, a 74.89% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-12-31 was $1.10M.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2017 was $276.26K, a 91.09% decline from fiscal 2016.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2016 was $3.10M.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-29 | ||
| 2017-12-31 | $276.26K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $276.26K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $3.10M 10-K · filed 2018-03-22 | |
| 2016-09-30 | $2.00M 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |